Work

Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors

Year: 2008

Type: article

Study design: Clinical Trial

Source: Cancer Biotherapy and Radiopharmaceuticals

DOI: 10.1089/cbr.2007.0448

Authors: Ebrahim S. Delpassand, Jennifer Sims-Mourtada, Hitomi Saso, Ali Azhdarinia, Faramarz Ashoori, Farzad Torabi, Gregory Espenan, Warren H. Moore, Eugene Woltering, Lowell Anthony

Institutions: Excel Diagnostics Imaging, RadioIsotope Therapy of America Foundation, RadioMedix (United States), Lubrizol Life Science Health (United States), Baylor College of Medicine, Louisiana State University Health Sciences Center New Orleans

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1990107189

FWCI: 4.588

Cites: 33

Cited by: 52

Related to: 10